TGFB1 and breast carcinoma: By applying quantitative proteomics and cell biological approaches we show that lysosomal protease inhibition results in accumulation of lysosomes and lysosome-related proteins thereby significantly reducing invasion of TGFβ-1 treated breast cancer cells but not of normal mammary epithelial cells.